Aller au contenu principal
Profil bibliographique

Ryo Iketani

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

28Publications signalées
178Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Pharmacy and Medical PracticesParkinson's Disease Mechanisms and TreatmentsMedication Adherence and ComplianceHepatitis C virus researchPharmaceutical Practices and Patient Outcomes

Les publications récentes

Accès ouvert 2026 article OpenAlex

Family Pharmacist System for Patients With Chronic Cardiovascular or Endocrine Disease

Ryo Iketani, Shinobu Imai

Importance: Japan's family pharmacist system (FPS) has helped to prevent therapeutic duplication and drug interactions and to improve leftover drug adjustments. However, its association with lower risk of death or hospitalization remains unclear. Objective: To examine the risk of death or hospitalization …

jp (code pays fourni par la source)

0 citations JAMA Network Open
Accès ouvert 2025 article OpenAlex

Effectiveness of the kakaritsuke-yakuzaishi (family pharmacist) system for underage individuals in Japan: a cohort study using a health insurance claims database

Ryo Iketani

BACKGROUND: The kakaritsuke-yakuzaishi system (hereafter called the family pharmacist system), which provides more pharmaceutical services in exchange for higher fees than do general pharmacy practices, was introduced in Japan in April 2016. This cohort study aimed to describe the characteristics of patients …

jp (code pays fourni par la source)

1 citation BMC Health Services Research
Accès ouvert 2023 article OpenAlex

Prescription Trends for the Antidiabetic Agents Used to Treat Type 2 Diabetes Mellitus in Japan from 2012–2020: a Time-Series Analysis

Ryo Iketani, Shinobu Imai

In April 2014, sodium-glucose cotransporter 2 inhibitor (SGLT-2i) was introduced in Japan. In May 2015, the prescription limitation for SGLT-2i was lifted. Subsequently, SGLT-2i was shown to reduce cardiovascular events in patients with type 2 diabetes mellitus (T2DM). SGLT-2i prescription is expected …

la, jp (code pays fourni par la source)

18 citations Biological and Pharmaceutical Bulletin
Accès ouvert 2022 article OpenAlex

Impact of breakthrough trials on prescription trends of sodium‐glucose cotransporter‐2 inhibitors in Japan: An interrupted time‐series analysis

Ryo Iketani, Shinobu Imai

WHAT IS KNOWN AND OBJECTIVE: Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) have been increasingly prescribed for the treatment of type 2 diabetes mellitus (T2DM). We aimed to investigate the impact of clinical trials presenting remarkable results on the prescription of SGLT-2is and the relationship …

jp (code pays fourni par la source)

2 citations Journal of Clinical Pharmacy and Therapeutics
Accès ouvert 2022 article OpenAlex

Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database

Ryo Iketani, Keiko Konomura

BACKGROUND: The kakaritsuke-yakuzaishi system (henceforth, the family pharmacist system) which provides more health services than those by general pharmaceutical practice, was implemented in Japan in April 2016. To distribute medical resources and medical care expenditures appropriately, identifying the possible major beneficiaries of …

jp (code pays fourni par la source)

12 citations BMC Health Services Research
Accès ouvert 2021 article OpenAlex

Utility of the Family Pharmacist System:

Ryo Iketani, Keiko Konomura

This retrospective cohort study aimed to evaluate the utility of the family pharmacist system using administrative claims data. The eligible cohort was detected from the JMDC claims database; it was divided into two groups-those using the system (users) and those not using …

la (code pays fourni par la source)

4 citations Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Accès ouvert 2021 article OpenAlex

Identification of Patients with Type 2 Diabetes Mellitus Requiring Concentrated Pharmaceutical Management in Health Insurance Pharmacies:

Ryo Iketani, Keiko Konomura

The present nested case-control study aimed to clarify the type of patients with type 2 diabetes mellitus that required concentrated pharmaceutical management in health insurance pharmacies by detecting factors associated with the calculation of chouhukutouyaku-sougosayoutou-boushi-kasan. We detected the factors of patients on …

la (code pays fourni par la source)

3 citations Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.